Having trouble accessing articles? Reset your cache.

Roche reports Phase II data for lung cancer candidate

Roche (SIX:ROG; OTCQX:RHHBY) reported preliminary data from the Phase II OAM4558g trial of

Read the full 138 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE